Vaxart, Inc.
VXRT
$0.68
$0.033.91%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.33M | -50.70M | -56.64M | -58.12M | -66.95M |
| Total Depreciation and Amortization | 8.58M | 8.76M | 8.90M | 8.92M | 8.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.37M | 7.10M | 7.29M | 8.56M | 10.07M |
| Change in Net Operating Assets | -22.56M | 4.55M | 3.36M | 7.47M | 3.26M |
| Cash from Operations | 7.71M | -30.29M | -37.09M | -33.17M | -44.76M |
| Capital Expenditure | -145.00K | -188.00K | -80.00K | -553.00K | -554.00K |
| Sale of Property, Plant, and Equipment | 5.00K | 5.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.77M | 25.23M | 13.91M | -2.52M | -20.77M |
| Cash from Investing | 16.63M | 25.05M | 13.83M | -3.07M | -21.32M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.62M | 3.04M | 3.04M | 41.16M | 59.54M |
| Repurchase of Common Stock | -199.00K | -184.00K | -190.00K | -200.00K | -215.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -184.00K | -2.76M | -2.76M | -2.76M | -2.76M |
| Cash from Financing | 4.24M | 93.00K | 87.00K | 38.20M | 56.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.59M | -5.16M | -23.17M | 1.96M | -9.53M |